These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 17314931

  • 1. Bone metastasis: can osteoclasts be excluded?
    Martin TJ, Mundy GR.
    Nature; 2007 Feb 22; 445(7130):E19; discussion E19-20. PubMed ID: 17314931
    [Abstract] [Full Text] [Related]

  • 2. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K, Le Goff B, Charrier C, Battaglia S, Heymann D, Rédini F.
    Bone; 2007 Apr 22; 40(4):981-90. PubMed ID: 17196895
    [Abstract] [Full Text] [Related]

  • 3. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC.
    Prostate; 2008 Jan 01; 68(1):92-104. PubMed ID: 18008334
    [Abstract] [Full Text] [Related]

  • 4. The RANK/RANKL/OPG triad in cancer-induced bone diseases.
    Dougall WC, Chaisson M.
    Cancer Metastasis Rev; 2006 Dec 01; 25(4):541-9. PubMed ID: 17180711
    [Abstract] [Full Text] [Related]

  • 5. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M, Matsuo K, Tada T, Fukushima H, Furuta H, Ozeki S, Kadowaki T, Yamamoto K, Okamoto M, Jimi E.
    Carcinogenesis; 2011 Nov 01; 32(11):1634-40. PubMed ID: 21890459
    [Abstract] [Full Text] [Related]

  • 6. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mochizuki S, Ikeda T, Mukai M, Okada Y.
    J Pathol; 2009 Aug 01; 218(4):530-9. PubMed ID: 19455604
    [Abstract] [Full Text] [Related]

  • 7. RANKL signaling in bone physiology and cancer.
    Dougall WC.
    Curr Opin Support Palliat Care; 2007 Dec 01; 1(4):317-22. PubMed ID: 18685382
    [Abstract] [Full Text] [Related]

  • 8. RANK signalling in bone lesions with osteoclast-like giant cells.
    Won KY, Kalil RK, Kim YW, Park YK.
    Pathology; 2011 Jun 01; 43(4):318-21. PubMed ID: 21532526
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.
    Tat SK, Padrines M, Theoleyre S, Couillaud-Battaglia S, Heymann D, Redini F, Fortun Y.
    Bone; 2006 Oct 01; 39(4):706-15. PubMed ID: 16750945
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.
    Tanaka S.
    Am J Nephrol; 2007 Oct 01; 27(5):466-78. PubMed ID: 17652963
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Genomic approaches to bone and joint diseases. Mutations of RANK, OPG and RANKL genes found in humans].
    Kobayashi Y, Takahashi N.
    Clin Calcium; 2008 Feb 01; 18(2):202-9. PubMed ID: 18245890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.